Botox 100 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FQWD4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,828
Award facts
- Contract value 100% obligated
- $19,827.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $19,827.78 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Botox 100 unit vials. This firm fixed-price delivery order, issued on November 24, 2025, with an ultimate completion date of December 16, 2025, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. The order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion government-wide acquisition strategy established to provide comprehensive pharmaceutical and medical supply support to Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has demonstrated substantial capability as a critical pharmaceutical supplier within the federal military medical supply chain since its registration in the System for Award Management in 2001. The company's PPV-G GEN V prime vendor contract, awarded November 13, 2025, with a ceiling value of $499,999,999 and completion date of December 31, 2036, authorizes the Defense Logistics Agency to issue delivery orders for branded and generic prescription drugs, biologics, vaccines, and medical consumables. This structure enables DMS Pharmaceutical Group to fulfill recurring specialized pharmaceutical requirements across military healthcare operations globally, with the Botox delivery order representing one of numerous orders issued under this foundational contract vehicle.
Quick answers
Who was awarded contract SPE2DR26FQWD4?
SPE2DR26FQWD4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FQWD4 worth?
The government has obligated $19,828 on SPE2DR26FQWD4.
Is contract SPE2DR26FQWD4 an order under another contract?
Yes. SPE2DR26FQWD4 is a delivery order under SPE2DR25D9353, an indefinite delivery contract.
Was contract SPE2DR26FQWD4 competed?
The extent of competition for SPE2DR26FQWD4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award